Campion, Liah Z.
HRN: 22-14-46 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/23/2023
CO-AMOXICLAV 625MG (TAB)
01/23/2023
01/31/2023
PO
500mg
Q12
S/P NSVD; UTI
Waiting Final Action
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes